NUP214 and acute myeloid leukemia: Patients with DEK::NUP214 account for around 1% of all AML cases (1) and include both children (mean age 10 years) and adults (mean age 45 years) (29, 30); our data are in accordance with previous literature as DEK::NUP214fusion was present in four adults and a 15-year-old girl with AML.